Vaccine panel appointed by RFK Jr. loses member before first meeting
'Dr. Michael Ross decided to withdraw from [the Advisory Committee on Immunization Practices] during the financial holdings review required of members before they can start work on the committee,' said Andrew Nixon, a spokesman for Kennedy's health department. 'The sacrifice to serve on ACIP varies from member to member, and we appreciate Dr. Ross's willingness to go through this rigorous process. We would have benefited from his service and expertise on this committee. The meeting will go as planned and there will be a quorum.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
SHA to spend $6.5M on 77 new health-care positions across rural and remote Sask. communities
The Saskatchewan Health Authority (SHA) and the provincial government have announced 77 new and enhanced permanent full-time health-care positions across 30 rural and remote communities in the province. New positions include a wide range of clinical roles such as licensed practical nurses, registered nurses, registered psychiatric nurses, combined lab and x-ray technicians, medical radiation technologists and phlebotomists, SHA said in a news release Wednesday. They will be added to communities including Kindersley, Kipling, La Ronge, Leader, Maple Creek, Melville, Moose Jaw, Nipawin, North Battleford, Outlook, Porcupine Plain, Prince Albert, Redvers, Rosetown, Shaunavon, Shellbrook, Unity, Wadena and Weyburn, the release said. SHA said some of the jobs are new permanent full-time positions, while others are part-time positions being converted to permanent full-time. It said the move will reduce reliance on contract staff and allow for more consistent coverage of emergency departments. In total, $6.2 million will be put toward the positions. The money comes from recent changes to SHA's out-of-scope administrative leadership that reduced 26 senior positions and other corporate, management and support roles, according to the release. Some of these new positions will be eligible for the Saskatchewan Rural and Remote Recruitment Incentive (RRRI), which provides up to $50,000 over three years, the SHA said. The announcement stems from the province's Health Human Resources Action Plan, launched in 2022 to recruit, train, incentivize and retain-health care workers in Saskatchewan, SHA said. SHA said it has already put $4.2 million toward the creation of 27 new and 20 enhanced clinical manager positions across 45 rural and northern communities.
WebMD
20 minutes ago
- WebMD
Mastectomy or Lumpectomy? Reassuring New Data for Young Women
July 23, 2025 – Young women diagnosed with breast cancer may not need to choose aggressive surgery to reduce recurrence risk. New research suggests the likelihood of cancer recurring (coming back) in the same breast or nearby lymph nodes isn't related to her choice of surgical treatment – removing either the cancerous tissue (lumpectomy) or one or both breasts (mastectomy). And for women 40 and under with invasive but not incurable cancer, recurrence risk across the board was "low" – just 5.6% over 10 years. "Many young women with breast cancer choose to have bilateral mastectomies even if they may be a candidate for a smaller surgery," said study author Laura S. Dominici, MD, a breast surgeon at Dana-Farber Cancer Institute and Mass General Brigham in Boston. "We know survival isn't impacted by this choice, but historically, young women were felt to have higher risk for local recurrence and tend to have more 'aggressive' breast cancers." The new findings, published Wednesday in JAMA Surgery, suggest that "women cannot make a bad choice," Dominici said. "A woman who wants to keep her breast isn't trading off a cancer outcome to do so." Of the more than 1,100 people in the study, 30% had lumpectomy, 26% had a single mastectomy, and 43% had bilateral mastectomy. When researchers analyzed surgical treatment alongside cancer subtype – such as whether it was related to hormones or certain genes – they found no significant differences in recurrence rates. Researchers attributed the low risk to advances in cancer treatments, which have become more targeted. Breast cancer patients in the study were diagnosed between 2006 and 2015, and they received optimal treatment after surgery – meaning breast cancer in young women may not be as likely to come back as older research suggested. Does This Research Apply to Me? The study included women age 40 or younger with stage I, II, or III breast cancer of any subtype – meaning hormone receptor-positive, triple negative, or any ERBB2 (formerly HER2) genetic status. If that describes you, you may want to talk to your doctor about it. The researchers excluded women with stage IV breast cancer (which has already spread to other parts of the body) and women with stage 0, or ductal carcinoma in situ or DCIS. "The results do require some caution in their generalizability because the patients were not from diverse populations, with nearly 85% non-Hispanic White women," Julie A. Margenthaler, MD, wrote in a commentary published with the study. Margenthaler was not involved in the study and is a breast cancer surgeon at WashU Medicine in St. Louis. What Type of Recurrence Did This Study Look For? It looked for local or regional recurrence (that is, in the same breast or surrounding lymph nodes), but not distant recurrence – when breast cancer returns in a distant part of the body like the brain or bones. That's a stage IV diagnosis, which is usually considered treatable but not curable. What About BRCA? About 1 in 10 women in the study had known BRCA genetic involvement, and most had mastectomies. "Women do not have to have a mastectomy in this setting, but many of them consider it," Dominici said. "Mastectomies will reduce the risk for future cancers (for which patients with BRCA mutations are at higher risk) but will not reduce risk for recurrence of the current cancer. A woman with BRCA mutation having lumpectomy should be doing high-risk screening with mammogram and MRI." Does This Mean I Should Get a Lumpectomy? When deciding what breast cancer surgery to have, you need to consider physical, emotional, and psychological factors, said Dominici, who is also a professor at Harvard Medical School. "There is no 'right' answer," she said, "and it is often hard for women to both appreciate and consider the short- and long-term impacts of the different surgeries." Lumpectomy may not be an option for some women with cancer in a significant portion or multiple areas of the breast, Dominici said. "Surgery is one important part of treatment, but systemic therapy and radiation are also key to lower risk for recurrence," she said.
Fast Company
20 minutes ago
- Fast Company
Taxpayer-funded vaccines meant to aid Africa are at risk of expiring
Hundreds of thousands of doses of mpox vaccine that the United States had promised to send to African nations are in danger of going to waste, dozens of congressional Democrats said in a letter to the U.S. State Department on Wednesday. Forty-eight Democratic members of the House of Representatives, led by Representatives Mark Pocan of Wisconsin and Sara Jacobs of California, signed the letter, saying that the vaccines may expire as they sit in warehouses, wasting the U.S. taxpayer dollars that paid for them. The letter said 800,000 doses of the vaccines are at risk, and that some 220,000 doses could be viable if the State Department begins shipping them immediately. 'This is a moral, strategic, and public health failure in the making,' the letter said. Republican U.S. President Donald Trump has made sharp cuts to foreign aid programs since beginning his second term six months ago, firing thousands of aid agency employees and contractors and throwing global humanitarian operations into chaos. The Republican-controlled Senate and House of Representatives passed legislation this month approving Trump's request for about $8 billion in foreign aid cuts. Trump has said the U.S. pays disproportionately for foreign aid, and he wants other countries to shoulder more of the burden. The World Health Organization first declared the outbreak of mpox in August 2024, when an outbreak of a new form of the disease spread from the badly-hit Democratic Republic of Congo to neighboring countries. Uganda and Burundi also have been significantly affected.
